Global Fibrinogen Deficiency (Factor I Deficiency) Clinical Trials Review 2016 - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2016" clinical trials to their offering.

Fibrinogen Deficiency (Factor I Deficiency) Global Clinical Trials Review, H2, 2016" provides an overview of Fibrinogen Deficiency (Factor I Deficiency) clinical trials scenario. This report provides top line data relating to the clinical trials on Fibrinogen Deficiency (Factor I Deficiency). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials).

Key Topics Covered:

  1. Tables & Figures
  2. Report Guidance
  3. Clinical Trials by Region
  4. Clinical Trials and Average Enrollment by Country
  5. Top Countries Contributing to Clinical Trials in Asia-Pacific
  6. Top Five Countries Contributing to Clinical Trials in Europe
  7. Top Countries Contributing to Clinical Trials in North America
  8. Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  9. Clinical Trials by G7 Countries: Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials
  10. Clinical Trials by Phase in G7 Countries
  11. Clinical Trials in G7 Countries by Trial Status
  12. Clinical Trials by E7 Countries: Proportion of Fibrinogen Deficiency (Factor I Deficiency) to Hematological Disorders Clinical Trials
  13. Clinical Trials by Phase in E7 Countries
  14. Clinical Trials in E7 Countries by Trial Status
  15. Clinical Trials by Phase
  16. In Progress Trials by Phase
  17. Clinical Trials by Trial Status
  18. Clinical Trials by End Point Status
  19. Subjects Recruited Over a Period of Time
  20. Clinical Trials by Sponsor Type
  21. Prominent Sponsors
  22. Top Companies Participating in Fibrinogen Deficiency (Factor I Deficiency) Therapeutics Clinical Trials
  23. Prominent Drugs
  24. Clinical Trial Profile Snapshots
  25. Appendix

Companies Mentioned

  • CSL Limited
  • Octapharma AG
  • Max India Limited
  • QED Clinical Services Limited
  • JSS Medical Research Inc.
  • Ministry of Health, France
  • China Biologic Products, Inc.
  • Biotest AG
  • ICON Plc
  • Grifols, S.A.

For more information about this clinical trials report visit http://www.researchandmarkets.com/research/8hzxpc/fibrinogen

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials, Hematological Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Clinical Trials, Hematological Drugs